Brain-derived neurotrophic factor ameliorates brain stem cardiovascular dysregulation during experimental temporal lobe status epilepticus

PLoS One. 2012;7(3):e33527. doi: 10.1371/journal.pone.0033527. Epub 2012 Mar 19.

Abstract

Background: Status epilepticus (SE) is an acute, prolonged epileptic crisis with a mortality rate of 20-30%; the underlying mechanism is not completely understood. We assessed the hypothesis that brain stem cardiovascular dysregulation occurs during SE because of oxidative stress in rostral ventrolateral medulla (RVLM), a key nucleus of the baroreflex loop; to be ameliorated by brain-derived neurotrophic factor (BDNF) via an antioxidant action.

Methodology/principal findings: In a clinically relevant experimental model of temporal lobe SE (TLSE) using Sprague-Dawley rats, sustained hippocampal seizure activity was accompanied by progressive hypotension that was preceded by a reduction in baroreflex-mediated sympathetic vasomotor tone; heart rate and baroreflex-mediated cardiac responses remained unaltered. Biochemical experiments further showed concurrent augmentation of superoxide anion, phosphorylated p47(phox) subunit of NADPH oxidase and mRNA or protein levels of BDNF, tropomyosin receptor kinase B (TrkB), angiotensin AT1 receptor subtype (AT1R), nitric oxide synthase II (NOS II) or peroxynitrite in RVLM. Whereas pretreatment by microinjection bilaterally into RVLM of a superoxide dismutase mimetic (tempol), a specific antagonist of NADPH oxidase (apocynin) or an AT1R antagonist (losartan) blunted significantly the augmented superoxide anion or phosphorylated p47(phox) subunit in RVLM, hypotension and the reduced baroreflex-mediated sympathetic vasomotor tone during experimental TLSE, pretreatment with a recombinant human TrkB-Fc fusion protein or an antisense bdnf oligonucleotide significantly potentiated all those events, alongside peroxynitrite. However, none of the pretreatments affected the insignificant changes in heart rate and baroreflex-mediated cardiac responses.

Conclusions/significance: We conclude that formation of peroxynitrite by a reaction between superoxide anion generated by NADPH oxidase in RVLM on activation by AT1R and NOS II-derived NO leads to a reduction in baroreflex-mediated sympathetic vasomotor tone during experimental TLSE; to be ameliorated by the upregulated BDNF/TrkB signaling via inhibition of p47(phox) phosphorylation. This information offers a new vista in devising therapeutic strategy towards minimizing mortality associated with TLSE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Animals
  • Antioxidants / metabolism*
  • Brain Stem
  • Brain-Derived Neurotrophic Factor
  • Cardiovascular System / metabolism*
  • Cardiovascular System / physiopathology
  • Cyclic N-Oxides / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Epilepsy, Temporal Lobe / metabolism*
  • Epilepsy, Temporal Lobe / pathology
  • Epilepsy, Temporal Lobe / physiopathology
  • Epilepsy, Temporal Lobe / therapy
  • Humans
  • Losartan / pharmacology
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Oxidative Stress / drug effects
  • Peroxynitrous Acid / metabolism
  • Phosphorylation / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Angiotensin, Type 1 / metabolism
  • Receptor, trkB / antagonists & inhibitors
  • Receptor, trkB / metabolism
  • Spin Labels
  • Status Epilepticus / metabolism*
  • Status Epilepticus / pathology
  • Status Epilepticus / physiopathology
  • Status Epilepticus / therapy
  • Superoxides / metabolism

Substances

  • Acetophenones
  • Antioxidants
  • Brain-Derived Neurotrophic Factor
  • Cyclic N-Oxides
  • Enzyme Inhibitors
  • RNA, Messenger
  • Receptor, Angiotensin, Type 1
  • Spin Labels
  • Superoxides
  • Peroxynitrous Acid
  • acetovanillone
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • NADPH Oxidases
  • neutrophil cytosolic factor 1
  • Receptor, trkB
  • Losartan
  • tempol